Response to the Commentary on “Is posttransplant lenalidomide the standard-of-care after an autotransplant for plasma cell myeloma”

Giovanni Barosi, Robert Peter Gale

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
JournalLeukemia
DOIs
Publication statusPublished - Jan 1 2019

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this